当前位置:首页 - 行情中心 - 金凯生科(301509) - 财务分析 - 利润表

金凯生科

(301509)

  

流通市值:19.55亿  总市值:41.49亿
流通股本:5674.09万   总股本:1.20亿

利润表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、营业总收入148,110,775.61639,372,322.65487,715,534.85348,402,686.2
  营业收入148,110,775.61639,372,322.65487,715,534.85348,402,686.2
二、营业总成本130,860,046.81527,563,152.44379,047,026.4270,016,513.94
  营业成本85,405,896.34367,697,980.68256,376,660.95188,932,640.79
  税金及附加1,832,789.138,148,741.725,292,279.153,777,170.16
  销售费用5,981,554.6324,790,883.3924,281,102.5416,221,759.62
  管理费用26,282,722.8393,558,831.0375,570,185.8250,254,811.89
  研发费用7,783,651.6735,911,621.2321,034,142.3514,169,623.42
  财务费用3,573,432.21-2,544,905.61-3,507,344.41-3,339,491.94
  其中:利息费用8,148.94193,016.7743,306.8727,309.46
  其中:利息收入2,650,915.3510,064,201.926,487,141.743,722,954.96
三、其他经营收益
  加:公允价值变动收益168,372.183,486,408.83,418,607.451,642,899.14
  加:投资收益2,644,613.7220,101,076.5516,201,877.2210,502,871.08
  资产减值损失(新)--16,107,234.43-11,371,818.14-9,305,221.34
  信用减值损失(新)-617,216.83-2,183,414.4-419,047.15-2,079,789.23
  其他收益700,768.44,250,707.763,680,111.213,160,129.51
四、营业利润20,147,266.27121,356,714.49120,178,239.0482,307,061.42
  加:营业外收入-397.5126,189.83126,306.5
  减:营业外支出30,780.56436,861.99174,195.0465,335.63
五、利润总额20,116,485.71120,920,250120,130,233.8382,368,032.29
  减:所得税费用3,472,987.9716,112,916.0416,700,913.3810,607,436.09
六、净利润16,643,497.74104,807,333.96103,429,320.4571,760,596.2
(一)按经营持续性分类
  持续经营净利润16,643,497.74104,807,333.96103,429,320.4571,760,596.2
(二)按所有权归属分类
  归属于母公司股东的净利润16,643,497.74104,807,333.96103,429,320.4571,760,596.2
  扣除非经常损益后的净利润13,775,798.4482,374,505.3684,414,780.3959,174,753.85
七、每股收益
  (一)基本每股收益0.140.870.860.6
  (二)稀释每股收益0.140.870.860.6
八、其他综合收益-2,515,906.64-3,253,787.46-3,465,005.78-900,767
  归属于母公司股东的其他综合收益-2,515,906.64-3,253,787.46-3,465,005.78-900,767
九、综合收益总额14,127,591.1101,553,546.599,964,314.6770,859,829.2
  归属于母公司股东的综合收益总额14,127,591.1101,553,546.599,964,314.6770,859,829.2
公告日期2026-04-252026-04-252025-10-252025-08-23
审计意见(境内)标准无保留意见
TOP↑